Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$591M |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$240M |
| 3 |
Boston Scientific
BSX
|
+$194M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$193M |
| 5 |
Clarivate
CLVT
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$809M |
| 3 |
Willis Towers Watson
WTW
|
+$664M |
| 4 |
AstraZeneca
AZN
|
+$658M |
| 5 |
Microsoft
MSFT
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.8% |
| 2 | Technology | 11.32% |
| 3 | Financials | 6.52% |
| 4 | Consumer Discretionary | 5.41% |
| 5 | Healthcare | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FIRY
3351
Firy Inc
FIRY
$172M
| $680K | ﹤0.01% |
3,464
+1,635
| +89% | +$423K |
|
3352
Outfront Media
OUT
$4.93B
| $678K | ﹤0.01% |
27,345
-35,629
| -57% | -$841K |
|
|
PACXU
3353
DELISTED
Pioneer Merger Corp. Unit
PACXU
| $677K | ﹤0.01% |
66,031
| – | – |
|
|
CLLS
3354
Cellectis
CLLS
$154M
| $675K | ﹤0.01% |
53,533
-6,081
| -10% | -$84.2K |
|
3355
Scansource
SCSC
$1.15B
| $675K | ﹤0.01% |
19,416
-4,217
| -18% | -$129K |
|
3356
Texas Capital Bancshares
TCBI
$4.13B
| $675K | ﹤0.01% |
11,239
-54,125
| -83% | -$3.37M |
|
3357
Ingles Markets
IMKTA
$1.57B
| $674K | ﹤0.01% |
10,203
-3,652
| -26% | -$232K |
|
3358
Kiniksa Pharmaceuticals
KNSA
$6.03B
| $674K | ﹤0.01% |
59,170
-99,785
| -63% | -$1.3M |
|
3359
Addus HomeCare
ADUS
$2.19B
| $672K | ﹤0.01% |
8,422
+155
| +2% | +$13.5K |
|
3360
Alliance Resource Partners
ARLP
$3.33B
| $672K | ﹤0.01% |
61,766
-1,338
| -2% | -$11.2K |
|
3361
Benchmark Electronics
BHE
$2.71B
| $670K | ﹤0.01% |
25,091
-6,876
| -22% | -$182K |
|
|
DNB
3362
DELISTED
Dun & Bradstreet
DNB
| $668K | ﹤0.01% |
39,734
-5,544
| -12% | -$106K |
|
3363
Sportsman's Warehouse
SPWH
$45.8M
| $668K | ﹤0.01% |
37,942
-20,276
| -35% | -$359K |
|
3364
Cactus
WHD
$4.65B
| $667K | ﹤0.01% |
17,693
+2,105
| +14% | +$75.9K |
|
3365
BRC Group Holdings
RILY
$240M
| $666K | ﹤0.01% |
11,286
-3,867
| -26% | -$253K |
|
|
ZEPP
3366
Zepp Health
ZEPP
$63.4M
| $666K | ﹤0.01% |
20,749
+19,887
| +2,307% | +$821K |
|
3367
Golar LNG
GLNG
$5.29B
| $665K | ﹤0.01% |
51,254
-115,508
| -69% | -$1.33M |
|
3368
S&T Bancorp
STBA
$1.77B
| $665K | ﹤0.01% |
22,566
-17,197
| -43% | -$507K |
|
|
TBI
3369
Trueblue
TBI
$272M
| $665K | ﹤0.01% |
24,539
-8,798
| -26% | -$235K |
|
|
NARI
3370
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $665K | ﹤0.01% |
8,201
-119
| -1% | -$10K |
|
|
RPTX
3371
DELISTED
Repare Therapeutics
RPTX
| $664K | ﹤0.01% |
25,305
-2,579
| -9% | -$83.3K |
|
|
CHNG
3372
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $663K | ﹤0.01% |
31,677
-1,088,978
| -97% | -$23.8M |
|
3373
RLI Corp
RLI
$5.45B
| $661K | ﹤0.01% |
13,184
-2,094
| -14% | -$111K |
|
3374
Franklin US Low Volatility High Dividend Index ETF
LVHD
$607M
| $659K | ﹤0.01% |
18,305
-15,523
| -46% | -$578K |
|
3375
JFrog
FROG
$11.4B
| $654K | ﹤0.01% |
19,516
-1,950
| -9% | -$78.3K |
|
Similar funds
Citigroup's Q3 2021 Portfolio in Review
As of Q3 2021, Citigroup held 6,611 positions worth $169B, up 1.9% from $166B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citigroup withdrew a net $12.2B in Q3 2021, closing 792 positions and reducing 2,705 holdings. Its most notable exit was Alexion Pharmaceuticals, an estimated $809M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 49% a quarter earlier, followed by Technology and Financials.
Against the trend, Citigroup opened a new position in Hennessy Capital Investment Corp. VI Unit worth $90.5M.
- Citigroup's largest Q3 2021 buy was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
- Citigroup added most to Invesco Dorsey Wright Momentum ETF in Q3 2021, an estimated $591M increase.
- Citigroup's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.25B.
- Citigroup fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $809M.
- Citigroup's ten largest holdings make up 25% of its $169B portfolio in Q3 2021.
- Citigroup opened 422 new positions and closed 792 in Q3 2021.
- Citigroup's portfolio value rose 1.9% quarter-over-quarter to $169B.
Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.